Eli Lilly Rises 1.6% While ResMed Falls 4% in Monday Trading
Eli Lilly experiences a 1.6% midday rise, boasting a 34% year-to-date gain, while ResMed sees a 4% decline, affecting stock market trends in pharmaceuticals and medical devices.
Eli Lilly shares were up 1.6% at midday Monday, with a 34% gain year-to-date, while ResMed shares dropped 4%.